FibroGen
ID: 5290514A biopharmaceutical company focused on developing treatments for anemia, idiopathic pulmonary fibrosis, pancreatic cancer, Duchenne muscular dystrophy and corneal blindness
1
Funding Rounds
$6.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Je***** He******* | - | - | |
| Su***** Bl*** | - | - | - |
| Ja*** A. Sc******* | - | - | - |
| Ao*** Br***** |
|
- | |
| Ma**** Ho | - | - | |
| Be****** Cr***** | - | - | - |
| En***** Co****** | - | - | |
| Ge**** Le** | - | - | - |
Funding series
Funding Series Analysis
The company FibroGen has raised a total of $6.02m in funding over 1 rounds.
Key Insights:
- FibroGen funding round, July 2012: $6.02m
Industries
FibroGen is active in the following industries: